Trial Profile
Second-line chemotherapy with temozolomide in recurrent oligodendroglial tumors after PCV [procarbazine, lomustine, vincristine]-chemotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2015
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 02 Oct 2005 New trial record.